SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals board to consider dividend

27 Apr 2026 Evaluate
Acutaas Chemicals has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, April 30, 2026 to consider the recommendation of Final Dividend for the FY2025-26 to the equity shareholders of the Company, subject to the approval by members in the ensuing Annual General Meeting. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with our intimation letter dated March 25, 2026 Trading Window for dealing in shares of the Company by designated persons, has been closed from April 1, 2026 and shall reopen on May 4, 2026.

The above information is a part of company’s filings submitted to BSE.

Acutaas Chemicals Share Price

2721.70 39.05 (1.46%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×